IGF-DES – (1-3) Analog-2mg

$99.00

IGF-1 DES (Des(1–3) Insulin-like Growth Factor-1) is a truncated isoform of native IGF-1 in which the first three amino acids are removed from the N-terminal. This modification significantly enhances biological potency by reducing binding to IGF-binding proteins (IGFBPs), thereby increasing free bioactive IGF-1 at tissue sites. IGF-1 DES is characterized by its short half-life and localized activity, making it particularly useful in research on targeted muscle hypertrophy, tendon repair, skin rejuvenation, and site-specific regenerative protocols.

SKU: BBT-US-30-699785
Products specifications
SPEC
2.0mg
FORM
Lyophilized powder
PRICE BREAKS - The more you buy, the more you save
Quantity 1+ 10+
Price $99.00 $94.00

1. 什么是IGF-1 DES?


IGF-1 DES(Des(1–3) Insulin-like Growth Factor-1)是天然IGF-1的截短同工型,其中从N端移除了前三个氨基酸。这种修饰显著增强了生物活性,通过减少与IGF结合蛋白(IGFBPs)的结合,从而在组织部位增加游离的生物活性IGF-1。
IGF-1 DES的特点是
半衰期短和局部活性,使其在靶向肌肉肥大、肌腱修复、皮肤年轻化和特定部位再生协议的研究中特别有用。


2. IGF-1 DES 结构

 

序列:TLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKAAKSA

分子式:  C₃₁₉H₅₀₁N₉₁O₉₆S₇ 

分子量:7371 g/mol

PubChem CID: 135331146

CAS 号:112603-35-7

Synonyms: Insulin-like growth factor 1, des-(1-3)-, Des(1-3) IGF-1, 4-70-insulin-like growth factor 1


3. IGF-1 DES Research

⚙️ Mechanism of Action

Enhanced IGF-1R Binding: Strong stimulation of PI3K/Akt/mTOR and MAPK/ERK pathways, promoting proliferation, hypertrophy, and tissue repair 1.

Reduced IGFBP Affinity: Lower sequestration by IGFBPs, resulting in higher localized activity 2.

Localized Action: Very short half-life (~20–30 minutes) ensures effects are site-specific, unlike IGF-1 LR3 which acts systemically.

📊 Research Highlights

In vitro and animal studies confirm myoblast differentiation, satellite cell activation, and angiogenesis at microinjury sites.

Investigated for use in localized muscle hypertrophy, tendon/joint recovery, and dermal repair following trauma or procedures.

Expert Commentary

Hormone Research in Paediatrics: “IGF-1 DES is particularly suitable for site-directed therapy where regional enhancement of IGF-1 signaling is required without systemic GH elevation.”

Peptides in Regenerative Medicine (2023): “Its short half-life allows for precision regenerative therapy with minimized systemic exposure.”


Why Consider IGF-1 DES?

🔬 10× potency at target tissue vs. native IGF-1

💪 Ideal for localized hypertrophy & injury site-specific healing

🧬 Avoids IGFBP sequestration, maximizing receptor binding

🛠️ Effective in regenerative research for muscle, tendon, and skin repair

⏳ Short duration = lower systemic exposure and minimized hormonal disruption


4. Future IGF-1 DES Research

·  A. Orthopedic & Tendon Regeneration
Studies on Achilles tendinopathy, rotator cuff tears, and ligament injuries, aiming for accelerated collagen remodeling
3.

·  B. Targeted Muscle Growth & Rehabilitation
Evaluated in post-injury recovery and resistance training models to restore lost muscle volume.

·  C. Anti-Aging Dermatology
Combined with microneedling or laser therapy for wrinkle reduction, scar remodeling, and stretch mark repair.

·  D. Neuroregeneration
Explored for localized recovery in peripheral nerve injury and spinal disc degeneration, with evidence of IGF-1–mediated neurogenesis
4.

·  E. Delivery Innovations
Development of topical hydrogel, microemulsion, and scaffold-based delivery systems, often paired with BPC-157, TB-500, or GHK-Cu.


5. Application Area

🧪 Tissue Repair & Regeneration
Muscle microtears, tendon strengthening, ligament healing.

💪 Localized Muscle Growth
Site-specific hypertrophy, post-surgical muscle atrophy prevention.

🧖 Dermatology & Skin Healing
Collagen regeneration, scar reduction, dermal rejuvenation.

🧠 Nerve & Spine Recovery
Peripheral nerve trauma, spinal disc support, neuron-glia repair.

🛡️ Surgical & Post-Procedural Recovery
Applied in research with PRP, stem cells, or microneedling to enhance ECM rebuilding and angiogenesis.


Summary

IGF-1 DES is a localized, short-acting IGF-1 analog with distinct regenerative potential:
✔️ 10× potency at tissue sites
✔️ Minimal IGFBP interference for higher free activity
✔️ Ideal for site-directed muscle, tendon, and skin repair
✔️ Low systemic exposure due to short half-life
✔️ Compatible with regenerative peptide and cell-based protocols


Disclaimer


ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.


本网站提供的产品仅供体外研究使用。体外研究(拉丁语:“在玻璃中”)是在体外进行的。这些产品不是药物或药品,尚未被FDA批准用于预防、治疗或治愈任何医疗状况、疾病或病症。严禁将任何种类的产品引入人体或动物体内,违者将受到法律的严厉制裁。

 

Only registered users can write reviews